Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients
Conditions
Long COVID · Post-Acute COVID-19 Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Shanghai Changhai Hospital, Shanghai, China
Study leads
Yuchao Dong, Doctor
Study Director
Changhai Hospital